Vale SA
VALE
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
4
Strategy
MSTR
5
Microsoft
MSFT
US Stock MarketDetailed Quotes
SAGE Sage Therapeutics
- 7.665
- -0.025-0.33%
Trading Mar 13 13:37 ET
471.25MMarket Cap-1.16P/E (TTM)
7.920High7.630Low724.15KVolume7.640Open7.690Pre Close5.64MTurnover1.34%Turnover RatioLossP/E (Static)61.48MShares20.32052wk High1.01P/B415.64MFloat Cap4.62052wk Low--Dividend TTM54.23MShs Float195.970Historical High--Div YieldTTM3.77%Amplitude4.620Historical Low7.793Avg Price1Lot Size
Sage Therapeutics Key Stats
EPS
According to the latest financial report of Sage Therapeutics, the latest earnings per share (TTM) for the company is -1.56. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Sage Therapeutics's free cash flow? The latest report shows it as -66.56M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Sage Therapeutics shows that the company's current ratio is 7.42, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Sage Therapeutics, the quick ratio is 7.17, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Sage Therapeutics? The latest ROE figure is -18.84%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Sage Therapeutics, the total asset return on investment (ROA) is -16.38%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Sage Therapeutics's latest financial report to see how their gross margin is doing - currently at 88.38%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Sage Therapeutics, the net profit margin is -747.33%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!